$0.7800
0.022.24%
Pre-Market: 7:19 PM EDT
Comments
Loading...
Century Therapeutics (IPSC) Forecast
NewsEarningsCentury Therapeutics (IPSC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCentury Therapeutics (NASDAQ:IPSC) Stock Quotes, Forecast and News Summary
Century Therapeutics Stock (NASDAQ: IPSC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Century Therapeutics (IPSC) stock?
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Who are Century Therapeutics (IPSC) competitors?
Other companies in Century Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).
What is the forecast, or price target, for Century Therapeutics (IPSC) stock?
Century Therapeutics has a consensus price target of $11.75.
What is the current price for Century Therapeutics (IPSC)?
The stock price for Century Therapeutics (NASDAQ: IPSC) is $0.78 last updated February 6, 2025 at 7:19 PM EST.
Does Century Therapeutics (IPSC) pay a dividend?
There are no upcoming dividends for Century Therapeutics.
When is Century Therapeutics (NASDAQ:IPSC) reporting earnings?
Century Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.
Is Century Therapeutics (IPSC) going to split?
There is no upcoming split for Century Therapeutics.
What sector and industry does Century Therapeutics (IPSC) operate in?
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.